Anti-2019 nCoV (N)Ig ELISA Kit (UNFI0090)

Built for SARS-CoV-2 serology research, this Assay Genie immunoassay kit captures and detects immunoglobulins directed against the viral nucleocapsid (N) protein. Researchers deploy it for vaccine immunogenicity studies, seroprevalence surveys, and longitudinal monitoring of humoral immunity, particularly where distinguishing infection-induced from vaccine-induced responses matters. Because the N protein is more conserved across variants than the spike protein, anti-N antibody screening remains informative as the virus evolves. The platform relies on enzymatic chromogenic signal generation, where absorbance intensity scales with anti-N immunoglobulin (Ig) bound from the specimen. Configured for in vitro research use only, the 96 Assays kit supplies pre-coated strips, detection reagents, wash buffer, substrate, and stop solution to complete the workflow per the included protocol. The assay accepts serum or plasma specimens, supporting work in academic, clinical research, and public health laboratories investigating exposure patterns, antibody durability, and cohort-level immunity profiles.